Vendor, New Haven, CT, part of Astrazeneca UK Ltd.
Alexion Pharmaceuticals Inc.
UEI DKCXLGANZAN3, CAGE 4EXK1
1 award and $104,650 obligated between July 21, 2026 and July 21, 2026, 100% under full and open competition.
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $104,650 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| BPA Call | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36C24526N0739BPA Call, July 21, 2026, Full and Open Competition | 245-Network Contract Office 5Department of Veterans Affairs | Strensiq 80 MGNAICS 325412, PSC 6505 | $104,650 |
- Places of performance
- Texas
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 1 across 1 awards